The Use of Aromatase Inhibitors for Ovulation Induction and Superovulation
review
OA: bronze
CC0
⤵ 10 in-corpus citations
AI-generated summary
Aromatase inhibitors show promise as safe and effective alternatives to clomiphene citrate for inducing ovulation and superovulation in infertile patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
CONTEXT: Anovulation is likely responsible for 20% of female infertility. Although clomiphene citrate remains the first-line therapy for ovulation induction in anovulatory patients who are not estrogen-deficient and to treat unexplained infertility, there remains a discrepancy between ovulation and conception rates with its use, attributed to its antiestrogenic effects on cervical mucus and the endometrium. Alternative agents, including aromatase inhibitors, have been used that have not been associated with these side effects. EVIDENCE ACQUISITION: A literature search was conducted to specifically explore the use of aromatase inhibitors for ovulation induction and superovulation. EVIDENCE SYNTHESIS: Recent studies have found that aromatase inhibitors may be safe and useful agents for ovulation induction in patients with polycystic ovarian syndrome as well a treatment option for superovulation in patients with either unexplained infertility or endometriosis. CONCLUSIONS: Aromatase inhibitors may be an effective alternative treatment to clomiphene citrate for both ovulation induction and superovulation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase inhibitors for the treatment of endometriosis via openalex
- Aromatase inhibitors in post-menopausal endometriosis via openalex
- Endometriosis via openalex
- Expression of Concern: Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis via openalex
- Letrozole vs. clomiphene citrate in patients with ovulatory infertility via openalex
- Pharmacological Treatment of Endometriosis via openalex
- doi:10.1016/s0002-9378(98)70238-8 via openalex
- doi:10.1016/0960-0760(95)00045-2 via openalex
- doi:10.1016/j.fertnstert.2012.09.022 via openalex
- doi:10.1016/0960-0760(94)90274-7 via openalex
- doi:10.1210/edrv-11-2-221 via openalex
- doi:10.1007/s00404-008-0888-9 via openalex
- doi:10.1210/jc.2005-1923 via openalex
- doi:10.1016/j.fertnstert.2005.07.230 via openalex
- doi:10.1097/00006254-196512000-00001 via openalex
- doi:10.1023/a:1008388823113 via openalex
- doi:10.1016/j.ajog.2004.08.013 via openalex
- doi:10.1038/bjc.1996.531 via openalex
- doi:10.1016/j.fertnstert.2012.10.008 via openalex
- doi:10.1016/j.fertnstert.2007.08.065 via openalex
- W2134004096 via openalex
- doi:10.1016/j.fertnstert.2012.09.042 via openalex
- W2167514715 via openalex
- W2438288971 via openalex
- W2799274998 via openalex
- W6679698060 via openalex
- W6684972698 via openalex
- W6717957469 via openalex
- doi:10.1016/j.fertnstert.2010.06.008 via openalex
- doi:10.1016/j.fertnstert.2009.07.985 via openalex
- doi:10.1016/j.fertnstert.2007.05.010 via openalex
- doi:10.1177/147323000603400109 via openalex
- doi:10.1016/j.fertnstert.2006.03.014 via openalex
- doi:10.1016/j.fertnstert.2007.10.016 via openalex
- doi:10.1007/s00404-010-1566-2 via openalex
- doi:10.1016/j.fertnstert.2008.06.013 via openalex
- doi:10.1016/s0015-0282(02)03975-4 via openalex
- doi:10.1210/jcem-36-2-207 via openalex
- doi:10.1016/j.fertnstert.2007.08.044 via openalex
- doi:10.2165/00003495-200666170-00001 via openalex
- doi:10.1186/1477-7827-9-84 via openalex
- doi:10.1080/00016340601090337 via openalex
- doi:10.1111/j.1365-2265.2011.04006.x via openalex
- doi:10.1016/j.fertnstert.2006.02.097 via openalex
- doi:10.1016/s0015-0282(00)01705-2 via openalex
- doi:10.1097/grf.0b013e3182353d0f via openalex
- doi:10.1080/00016340802638199 via openalex
- doi:10.1016/s0306-3356(21)00138-2 via openalex
Cited by (10)
- Evaluating the Relative Efficacy of Synthetic and Natural Drugs in Endometriosis Adopting Molecular Modelling Approach 2024
- Expectant, Medical, and Surgical Management of Ovarian Endometriomas 2023
- Pentoxifylline for the treatment of endometriosis-associated pain and infertility 2021
- Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure 2019
- Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study 2017
- Genome-wide Long Non-coding RNA Analysis Identified Circulating LncRNAs as Novel Non-invasive Diagnostic Biomarkers for Gynecological Disease 2016
- Aromatase inhibitors in the treatment of endometriosis 2016
- Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? 2016
- Aromatase Expression in Endometriosis and Its Significance 2014
- Potential role of aromatase inhibitors in the treatment of endometriosis 2014
Source provenance
- europepmc
- last seen: 2026-09-01T06:12:48.306406+00:00
- openalex
- last seen: 2026-05-11T03:31:18.316767+00:00
- pubmed
- last seen: 2026-05-13T22:19:05.543671+00:00
License: CC0
· commercial use OK